نتایج جستجو برای: atorvastatin

تعداد نتایج: 5060  

Ali Ghazavi Fardin Faraji Ghasem Mosayebi, Keyvan Ghasami Masoud Fazeli

Background: Statins, widely used cholesterol-lowering agents, have also been demonstrated to have anti-inflammatory and immunomdulatory effects. Objective: To evaluate the effects of atorvastatin in combination with Interferon-β in the treatment of multiple sclerosis (MS) in a randomized controlled clinical trial. Methods: Multiple sclerosis patients were randomized independently, in a double b...

Aminoglycosides are still widely used for treatment of gram-negative sepsis in critically ill patients. The most reported electrolyte abnormalities related to these drugs are hypokalemia, hypomagnesemia, and hypocalcemia. In this study potential benefit of atorvastatin in prevention of amikacin-induced electrolytes imbalances has been evaluated. In this trial 44 patients were assigned to the at...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2002
Sven Wassmann Ulrich Laufs Kirsten Müller Christian Konkol Katja Ahlbory Anselm T Bäumer Wolfgang Linz Michael Böhm Georg Nickenig

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) may exert direct effects on vascular cells and beneficially influence endothelial dysfunction. Because reactive oxygen species (ROS) may lead to vascular damage and dysfunction, we investigated the effect of atorvastatin on ROS production and the underlying mechanisms in vitro and in vivo. Cultured rat aortic vascular smooth m...

2016
Ali Monfared Seyyede Zeinab Azimi Ehsan Kazemnezhad

BACKGROUND Statins improve prognosis in patients with coronary heart diseases by decreasing the incidence of vascular events. Excess prevalence of hyperhomocysteinemia, an independent risk factor of cardiovascular diseases, has been observed in stable renal transplant recipients (RTRs). OBJECTIVES The objective of our study was to evaluate the association between atorvastatin administration a...

2017
Zoltan Varga Martina Nemcekova Slavka Carnicka Veronika Slezakova Miriam Petrova Marek Majdan Tana Ravingerova Viera Kristova

Statins reduce infarct size (IS) in ischemia-reperfusion injury of the myocardium. Inhibition of cyclooxygenase-2 (COX-2) attenuates this benefit. We investigated the effect of two widely used non-selective non-steroidal anti-inflammatory drugs (NSAIDs) with different degree of anti-COX-2 activity on atorvastatin-mediated preconditioning. Wistar rats received oral atorvastatin (10 mg∙kg-1∙day-1...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2007
Sei Nakata Masato Tsutsui Hiroaki Shimokawa Takahiro Yamashita Akihide Tanimoto Hiromi Tasaki Kiyoshi Ozumi Ken Sabanai Tsuyoshi Morishita Osamu Suda Hideyasu Hirano Yasuyuki Sasaguri Yasuhide Nakashima Nobuyuki Yanagihara

OBJECTIVE Three-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are known to enhance vascular expression of endothelial (eNOS) and inducible nitric oxide synthase (iNOS). In this study, we examined whether statins also upregulate vascular expression of neuronal NOS (nNOS). METHODS AND RESULTS In cultured rat aortic smooth muscle cells, treatment with atorvastatin ...

2011
Jee Eun Lee Rolf van Heeswijk Katia Alves Frances Smith Varun Garg

23 24 Purpose: Telaprevir is a hepatitis C virus protease inhibitor that is both a substrate and 25 an inhibitor of CYP3A. Amlodipine and atorvastatin are both substrates of CYP3A and 26 are amongst the drugs most frequently used by patients with hepatitis C. This study was 27 conducted to examine the effect of telaprevir on atorvastatin and amlodipine 28 pharmacokinetics (PK). 29 Methods: This...

Prevention and treatment of neuropathic pain (NP) is one of the most difficult problemsin clinical practice since the underlying mechanism of NP is unclear. In previous studies, theincreased production of nitric oxide (NO) has been closely linked to the induced NP. In thisstudy, we assessed the effect of atorvastatin through NO mechanism, on inflammation, thermalhyperalg...

Journal: :European heart journal 2005
Anton F H Stalenhoef Christie M Ballantyne Cinzia Sarti Jan Murin Serena Tonstad Helen Rose Wim Wilpshaar

AIMS The efficacy and safety of rosuvastatin, atorvastatin, and placebo were compared in patients with the metabolic syndrome. METHODS AND RESULTS Patients with the metabolic syndrome with low-density lipoprotein cholesterol (LDL-C) > or =3.36 mmol/L (130 mg/dL) and multiple risk factors conferring a 10-year coronary heart disease risk score of >10% were randomized (2:2:1) to receive rosuvast...

2018
Cuicui Chen Jingwen Ye Huankun Liang Jiali Li Xiaoxiao Guo Xipan Liu Shuhai Zhong Jiexing Li Laiqing Li Licheng Zhang Yongqing Wang

Background: This study was to investigate the clinical effect of high-dose atorvastatin on patients with acute cerebral infarction. Materials and Methods: 234 patients with acute cerebral infarction were randomized divided into control group (n=78), highdose atorvastatin (HDA) group (n=78) and low-dose atorvastatin (LDA) group (n=78). 80L group and 20L group were received lovastatin 80 mg/d or ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید